background
respiratori
picornavirus
enterovirus
rhinovirus
commonli
cite
caus
selflimit
upper
respiratori
tract
infect
howev
recent
suggest
may
caus
sever
respiratori
diseas
immunofluoresc
assay
rapid
inexpens
often
use
detect
respiratori
virus
object
sought
develop
procedur
use
commerci
avail
reagent
detect
respiratori
picornavirus
directli
nasopharyng
aspir
npa
studi
design
novemb
octob
npa
patient
respiratori
infect
stain
light
diagnost
panenteroviru
reagent
blend
ifenvpan
specimen
test
posit
stain
test
subject
avail
frozen
specimen
xtag
respiratori
viral
panel
multiplex
pcr
direct
respiratori
picornavirus
adenoviru
adv
respiratori
sincyti
viru
rsv
influenza
virus
b
ifa
ifb
parainfluenza
viru
piv
human
metapneumoviru
hmpv
coronavirus
result
npa
test
posit
ifenvpan
npa
avail
test
xtag
respiratori
viral
panel
multiplex
pcr
detect
respiratori
picornavirus
npa
sole
viral
pathogen
result
indic
potenti
ifenvpan
laboratori
detect
respiratori
picornavirus
clinic
specimen
far
awar
first
public
method
recent
studi
use
molecular
biolog
approach
suggest
previous
unsuspect
role
respiratori
picornavirus
enterovirus
rhinovirus
pathogenesi
sever
respiratori
tract
infect
acut
wheez
bronchiol
acut
asthma
viral
pneumonia
children
infant
exacerb
copd
asthma
cystic
fibrosi
sever
chronic
infect
immunolog
compromis
patient
sever
lower
respiratori
tract
infect
elderli
person
associ
respiratori
picornavirus
rapid
diagnosi
respiratori
viral
pathogen
import
help
prevent
spread
nosocomi
infect
minim
unnecessari
antibiot
usag
discern
need
antivir
therapi
immunofluoresc
wide
use
method
detect
mani
respiratori
virus
directli
respiratori
sampl
rapid
reliabl
cost
effect
method
provid
estim
specimen
qualiti
allow
screen
ing
sever
virus
simultan
howev
stain
specimen
detect
respiratori
picornavirus
consid
imposs
due
larg
number
serotyp
involv
nevertheless
use
specif
monoclon
antibodi
enteroviru
describ
identif
purpos
shell
vial
convent
cultur
conduct
preliminari
investig
suitabl
light
diagnost
panenteroviru
reagent
blend
ifenvpan
detect
respiratori
picornavirus
directli
nasopharyng
aspir
npa
although
conceiv
applic
frequent
observ
specif
fluoresc
cytoplasmat
granular
pattern
frequent
associ
npa
children
wheez
crossreact
hepat
astroviru
unlik
respiratori
sampl
adenovirus
could
ruledout
specif
stain
observ
suggest
possibl
associ
fluoresc
pattern
detect
respiratori
picornavirus
order
ass
suitabl
ifenvpan
detect
respiratori
picornavirus
directli
npa
prospect
test
npa
specimen
patient
suspect
viral
respiratori
infect
ifenvpan
stain
test
avail
ifenvpan
posit
specimen
xtag
respiratori
viral
panel
commerci
multiplex
pcr
direct
mani
respiratori
virus
includ
respiratori
picornavirus
nasopharyng
aspir
npa
collect
period
novemb
octob
children
adult
suspect
respiratori
infect
prospect
test
light
diagnost
panenteroviru
reagent
blend
ifenvpan
usual
screen
panel
respiratori
virus
adv
rsv
ifa
ifb
piv
hmpv
avail
excess
sampl
materi
frozen
c
ifenvpan
posit
npa
suffici
frozen
materi
test
xtag
respiratori
viral
panel
multiplex
pcr
direct
respiratori
picornavirus
adv
rsv
ifa
ifb
piv
hmpv
coronavirus
total
number
ifenvpan
posit
npa
test
multiplex
pcr
everi
neg
npa
screen
panel
ifenvpan
collect
novemb
septemb
suffici
frozen
materi
also
test
xtag
multiplex
pcr
total
number
neg
specimen
test
multiplex
pcr
npa
collect
children
admit
emerg
room
depart
pediatr
bern
univers
switzerland
sampl
came
children
admit
hospit
sent
paediatrician
practic
adult
admit
univers
hospit
bern
switzerland
immuncompromis
patient
age
follow
year
year
year
year
adult
npasampl
vortex
centrifug
g
min
cell
pellet
resuspend
pb
centrifug
g
min
final
resuspend
pb
form
slightli
cloudi
suspens
one
drop
cell
suspens
place
well
multiwel
slide
dri
slide
fix
aceton
min
stain
slide
examin
fluoresc
microscop
sampl
contain
fewer
ciliat
epitheli
cell
consid
inadequ
well
stain
light
diagnost
chemicon
intern
part
millipor
temecula
ca
respiratori
viral
screen
dfa
singl
fluoresceinconjug
monoclon
antibodi
detect
adv
rsv
ifa
ifb
piv
diagnost
hybrid
dfa
metapneumoviru
identif
kit
detect
hmpv
accord
manufactur
instruct
specimen
also
test
light
diagnost
panenteroviru
reagent
blend
cat
contain
blend
two
monoclon
antibodi
separ
slide
use
ifenvpan
indirect
immunofluoresc
antibodi
assay
one
drop
monoclon
antibodi
place
well
incub
humid
chamber
c
min
slide
wash
pbstween
drop
antimous
igg
conjug
light
diagnost
cat
ad
well
slide
incub
way
wash
dri
examin
posit
result
indic
presenc
two
intact
cell
exhibit
specif
fluoresc
pattern
cytoplasm
posit
cell
appear
envelop
surfac
bright
applegreen
larg
grain
granular
fluoresc
mantl
fig
sampl
intranuclear
extracellular
fluoresc
regard
neg
rna
dna
extract
easymag
extractor
use
gener
protocol
l
npa
l
dilut
escherichia
coli
phage
atcc
strain
univers
transport
medium
copan
ad
intern
control
elut
volum
set
l
extract
store
c
xtag
respiratori
viral
panel
assay
luminex
molecular
diagnost
compris
follow
step
carri
accord
manufactur
instruct
targetspecif
reversetranscript
pcr
exonucleasephosphatas
treatment
targetspecif
primer
extens
targetspecif
hybrid
amplicon
fluorochromemark
microbead
detect
amplicon
luminex
instrument
detail
descript
method
see
merant
et
al
raw
data
output
file
consist
median
fluoresc
intens
virus
subtyp
interpret
use
tda
rvpi
softwar
luminex
molecular
diagnost
total
npa
specimen
avail
analysi
sampl
reject
inadequaci
ifresult
shown
tabl
npa
posit
rsv
adv
ifa
piv
hmpv
coinfect
observ
npa
patient
test
posit
dual
infect
anoth
respiratori
viru
rsv
adv
piv
hmpv
found
sampl
result
inconclus
specimen
due
nonspecif
background
stain
lack
granular
cluster
total
npa
ifenvpan
posit
neg
ifenvpan
screen
panel
test
xtag
multiplex
pcr
comparison
ifenvpanxtag
multiplex
pcr
result
shown
tabl
multiplex
pcr
detect
respiratori
picornavirus
sole
viral
pathogen
npa
posit
ifenvpan
npa
posit
ifenvpan
neg
multiplex
pcr
due
lack
frozen
materi
unabl
clarifi
discrep
six
npa
coinfect
rsv
suffici
frozen
materi
test
xtag
multiplex
pcr
multiplex
pcr
confirm
ifresult
six
npa
xtag
multiplex
pcr
detect
dual
infect
specimen
rsv
piv
piv
xtag
multiplex
pcr
detect
respiratori
picornavirus
rsv
ifa
coronavirus
adv
piv
piv
hmpv
neg
npa
multipl
viral
pathogen
detect
specimen
sampl
two
one
three
respiratori
virus
calcul
sensit
specif
ifenvpan
compar
xtag
multiplex
pcr
possibl
sampl
differ
ifenvpan
posit
neg
npa
describ
studi
design
compar
xtag
multiplex
pcr
ifenvpan
show
posit
predict
valu
neg
predict
valu
studi
evalu
procedur
detect
respiratori
picornavirus
npa
purpos
ifenvpan
compar
xtag
multiplex
pcr
multiplex
pcr
detect
respiratori
picornavirus
ifenvpan
posit
npa
viral
pathogen
recognit
posit
stain
pattern
present
particular
difficulti
experienc
laboratori
staff
ifenvpan
posit
npa
neg
use
xtag
multiplex
pcr
unfortun
discrep
specimen
could
retest
due
lack
frozen
materi
moreov
xtag
multiplex
pcr
confirm
ifresult
six
test
npa
rsv
coinfect
thu
crossreact
ifenvpan
respiratori
virus
appear
unlik
base
result
consid
npa
show
specif
cytoplasmat
granular
fluoresc
pattern
follow
ifenvpan
stain
truli
posit
respiratori
picornavirus
posit
predict
valu
ifenvpan
compar
xtag
multiplex
pcr
neither
ifenvpan
xtag
pcr
distinguish
enterovirus
rhinovirus
test
enteroviru
rhinoviru
specif
pcr
sequencingstudi
necessari
resolv
uncertainti
howev
probabl
rhinovirus
enterovirus
part
continu
spectrum
relat
virus
caus
relat
diseas
total
test
npa
posit
ifenvpan
respiratori
picornavirus
use
respiratori
picornavirus
second
frequent
detect
viral
pathogen
npa
first
subject
older
year
consid
data
support
suspect
high
frequenc
respiratori
picornavirus
viral
pathogen
describ
author
xtag
multiplex
pcr
detect
least
one
viral
pathogen
respiratori
picornavirus
neg
npa
thu
compar
sensit
detect
respiratori
virus
particularli
respiratori
picornavirus
given
wide
genet
variat
respiratori
picornavirus
possibl
monoclon
antibodi
blend
react
serotyp
present
hand
enhanc
sensit
molecular
method
compar
detect
respiratori
virus
regard
advantag
respiratori
picornavirus
also
detect
pcr
approxim
subject
lack
respiratori
symptom
moreov
least
two
report
document
recoveri
respiratori
picornavirus
pcr
week
follow
acut
respiratori
ill
detect
respiratori
picornavirus
nucleic
acid
repres
presenc
viru
without
correl
current
clinic
symptom
persist
viru
genom
follow
previou
infect
activ
infect
major
advantag
method
paradox
rel
insensitivityther
substanti
quantiti
viru
materi
present
score
posit
posit
result
correl
well
activ
infect
furthermor
much
flexibl
much
less
expens
molecular
procedur
result
avail
sever
time
day
within
h
prepar
new
specimen
begin
earlier
one
complet
reason
still
retain
advantag
pcr
firstlin
test
guid
clinician
sum
data
support
clinic
util
ifenvpan
stain
npa
detect
respiratori
picornavirus
particularli
infant
children
addit
ifenvpan
screen
target
adv
rsv
piv
ifa
ifb
hmpv
provid
complet
diagnosi
respiratori
viral
infect
none
